Paediatric Diabetic Ketoacidosis

Author: Richard Freeman, April Donne / Editor: John Scanlon, Richard Freeman / Reviewer: Jon Bailey / Codes: / Published: 10/06/2021

Description:

This session will explore the management of diabetic ketoacidosis in young people with relevance to the published evidence and national guidelines.

Learning Objectives:

  • Define the clinical & biochemical features of paediatric diabetic ketoacidosis
  • Understand the underlying pathophysiology
  • Identify the known risk factors
  • Commence initial management in the emergency department
  • Understand the principles that govern subsequent management
  • Identify & avoid potential complications
  • Identify & manage cases of suspected cerebral oedema
START MODULE

References:

  1. Hanas R, Lindgren F, Lindblad B. A 2-yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use. Pediatr Diabetes. 2009;10(1):33-37.
  2. Rosilio M, Cotton JB, Wieliczko MC, et al., Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. The French Pediatric Diabetes Group. Diabetes Care. 1998;21(7):1146-1153.
  3. Smith CP, Firth D, Bennett S, et al., Ketoacidosis occurring in newly diagnosed and established diabetic children. ActaPaediatr. 1998;87(5):537-541.
  4. Morris AD, Boyle DI, McMahon AD, et al., Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland Medicines Monitoring Unit. Lancet. 1997;350(9090):1505-1510.
  5. Rewers A, Chase HP, Mackenzie T, et al., Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287(19):2511-2518.
  6. Cengiz E, Xing D, Wong JC, et al., Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D exchange clinic registry. Pediatr Diabetes. 2013;14(6):447-454.
  7. Maahs DM, Hermann JM, Holman N, et al., Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015;38(10):1876-1882.
  8. Curtis JR, To T, Muirhead S, et al., Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002;25(9):1591-1596.
  9. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990-96. Arch Dis Child. 1999;81(4):318-323.
  10. Decourcey DD, Steil GM, Wypij D, et al., Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality. Pediatr Crit Care Med. 2013;14(7):694-700.
  11. Glaser N, Barnett P, McCaslin I, et al., Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344(4):264-269
  12. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85(1):16-22.
  13. Dabelea D, Rewers A, Stafford JM, et al., Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study. Pediatrics. 2014;133(4):e938-e945.
  14. Levy-Marchal C, Papoz L, de Beaufort C, et al., Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med. 1992;9(3):279-284.
  15. Komulainen J, Lounamaa R, Knip M, et al. Ketoacidosis at the diagnosis of type 1 (insulin dependent) diabetes mellitus is related to poor residual beta cell function. Childhood Diabetes in Finland Study Group. Arch Dis Child. 1996;75(5):410-415.
  16. Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Dibetes. Diabetologia. 2001;44((suppl 3)): B75-B80.
  17. Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden a 2-year paediatric population study. Diabet Med. 2007;24(10):1080-1085.
  18. Rodacki M, Pereira JR, Nabuco de Oliveira AM, et al., Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes. Diabetes Res Clin Pract. 2007;78(2): 259-262.
  19. Usher-Smith JA, Thompson M, Ercole A, et al., Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012;55(11):2878-2894.
  20. Fritsch M, Schober E, Rami-Merhar B, et al., Diabetic ketoacidosis at diagnosis in Austrian children: a population-based analysis, 1989-2011. J Pediatr. 2013;163: 1484-8.e1.
  21. Zucchini S, Scaramuzza AE, Bonfanti R, et al., A multicenter retrospective survey regarding diabetic ketoacidosis management in Italian children with type 1 diabetes. J Diabetes Res. 2016;2016:5719470.
  22. BSPED Interim Guideline for the Management of Children and Young People under the age of 18 years with Diabetic Ketoacidosis. British Society of Paediatric Endocrinology and Diabetes. [Accessed 7th April 2021].
  23. Dunger DB, Sperling MA, Acerini CL, et al., ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89(2):188-194.
  24. Sheikh-Ali M, Karon BS, Basu A, et al., Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008;31(4):643-647.
  25. Wolfsdorf JI, Glaser N, Agus M, et al., ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatric Diabetes. 2018;19:155-177.
  26. Chase HP, Garg SK, Jelley DH. Diabetic ketoacidosis in children and the role of outpatient management. Pediatr Rev. 1990;11(10): 297-304.
  27. Cope JU, Morrison AE, Samuels-Reid J. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events. Pediatrics. 2008;121(5):e1133-e1138.
  28. Carlotti AP, St George-Hyslop C, Guerguerian AM, et al., Occult risk factor for the development of cerebral edema in children with diabetic ketoacidosis: possible role for stomach emptying. Pediatr Diabetes. 2009;10(8):522-533.
  29. Davids MR, Edoute Y, Stock S, et al., Severe degree of hyperglycaemia: insights from integrative physiology. QJM. 2002;95(2): 113-124.
  30. Malone JI, Brodsky SJ. The value of electrocardiogram monitoring in diabetic ketoacidosis. Diabetes Care. 1980;3(4):543-547.
  31. Soler NG, Bennett MA, Fitzgerald MG, et al., Electrocardiogram as a guide to potassium replacement in diabetic ketoacidosis. Diabetes. 1974;23(7):610-615.
  32. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet1974;2(7872):81-4.
  33. Harris GD, Fiordalisi I. Physiologic management of diabetic ketoacidemia. A 5-year prospective pediatric experience in 231 episodes. Arch Pediatr Adolesc Med. 1994;148(10):1046-1052.
  34. Fiordalisi I, Novotny WE, Holbert D, et al., An 18-yr prospective study of pediatric diabetic ketoacidosis: an approach to minimizing the risk of brain herniation during treatment. Pediatr Diabetes. 2007;8(3):142-149.
  35. Edge JA, Jakes RW, Roy Y, et al., The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49(9):2002-2009.
  36. Leach, D. and Barton, J. 2021. Paediatric DKA Protocol Generator. [Accessed 7 April 2021].
  37. Tattersall RB. A paper which changed clinical practice (slowly). Jacob Holler on potassium deficiency in diabetic acidosis (1946). Diabet Med 1999;16(12):97884.
  38. Atchley D, Loeb R, Richards D Jr, Benedict E, et al., On diabetic ketoacidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest. 1933;12:297-326.
  39. Nabarro J, Spencer A, Stowers J. Metabolic studies in severe diabetic ketosis. Q J Med. 1952;82:225-248.
  40. Butler A, Talbot N, Burnett C, et al. Metabolic studies in diabetic coma. Trans Assoc Am Phys. 1947;60:102-109.
  41. Danowski T, Peters J, Rathbun J, et al., Studies in diabetic acidosis and coma, with particular emphasis on the retention of administered potassium. J Clin Invest. 1949;28:1-9.
  42. Darrow D, Pratt E. Retention of water and electrolyte during recovery in a patient with diabetic acidosis. J Pediatr. 1952;41:688-696.
  43. Hoorn EJ, Carlotti AP, Costa LA, et al., Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr. 2007; 150(5):467-473.
  44. Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet. 1987;2(8554):306-308.
  45. Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic ketoacidosis. Br Med J (Clin Res Ed). 1984; 289(6451):1035-1038.
  46. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986;105(6):836-840.
  47. Okuda Y, Adrogue HJ, Field JB, et al., Counterproductive effects of sodium bicarbonate in diabetic ketoacidosis. J Clin Endocrinol Metab. 1996;81(1):314-320.
  48. Green SM, Rothrock SG, Ho JD, et al., Failure of adjunctive bicarbonate to improve outcome in severe pediatric diabetic ketoacidosis. Ann Emerg Med. 1998;31(1):41-48.
  49. Assal JP, Aoki TT, Manzano FM, et al., Metabolic effects of sodium bicarbonate in management of diabetic ketoacidosis. Diabetes. 1974;23(5):405-411.
  50. Ohman JL Jr, Marliss EB, Aoki TT, et al., The cerebrospinal fluid in diabetic ketoacidosis. N Engl J Med. 1971;284(6):283-290.
  51. Soler NG, Bennett MA, Dixon K, et al. Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet. 1972;2(7779):665-667.
  52. Lever E, Jaspan JB. Sodium bicarbonate therapy in severe diabetic ketoacidosis. Am J Med. 1983;75(2):263-268.
  53. Palmer BF, Clegg DJ. Electrolyte and acid-base disturbances in patients with diabetes mellitus. N Engl J Med. 2015;373(6):548-559.
  54. Gibby OM, Veale KE, Hayes TM, et al., Oxygen availability from the blood and the effect of phosphate replacement on erythrocyte 2,3-diphosphoglycerate and haemoglobin-oxygen affinity in diabetic ketoacidosis. Diabetologia. 1978;15(5):381-385.
  55. Keller U, Berger W. Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma. Diabetes. 1980;29(2):87-95.
  56. Wilson HK, Keuer SP, Lea AS, et al., Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982;142(3): 517-520.
  57. Becker DJ, Brown DR, Steranka BH, et al. Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis. Am J Dis Child. 1983;137(3):241-246.
  58. Fisher JN, Kitabchi AE. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J Clin Endocrinol Metab. 1983; 57(1):177-180.
  59. Clerbaux T, Reynaert M, Willems E, et al., Effect of phosphate on oxygen-hemoglobin affinity, diphosphoglycerate and blood gases during recovery from diabetic ketoacidosis. Intensive Care Med. 1989;15(8):495-498.
  60. Vanelli M, Chiari G, Capuano C, et al., The direct measurement of 3-beta-hydroxy butyrate enhances the management of diabetic ketoacidosis in children and reduces time and costs of treatment. Diabetes Nutr Metab. 2003;16(56):312-316.
  61. Noyes KJ, Crofton P, Bath LE, et al., Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes. 2007;8(3):150-156.
  62. Lawrence SE, Cummings EA, Gaboury I, et al., Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146(5): 688-692.
  63. Rosenbloom AL. Intracerebral crises during treatment of diabeticketoacidosis. Diabetes Care. 1990;13(1):22-33.
  64. Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children [letter]. Lancet. 1990;336(8706):64.
  65. Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developingbrain herniation during diabetic ketoacidosis. Pediatr Neurol. 1999;21(4):721-727.
  66. Durward A, Ferguson LP, Taylor D, et al., The temporal relationship between glucose-corrected serum sodium and neurological status in severe diabetic ketoacidosis. Arch Dis Child.2011;96:50-57.
  67. Bureau MA, Begin R, Berthiaume Y, et al., Cerebral hypoxia from bicarbonate infusion in diabetic acidosis. J Pediatr. 1980;96(6):968-973.
  68. Glaser NS, Marcin JP, Wootton-Gorges SL, et al., Correlation of clinical and biochemical findings with diabetic ketoacidosis-related cerebral edema in children using magnetic resonance diffusion-weighted imaging. J Pediatr. 2008;153(4):541-546.
  69. Durr JA, Hoffman WH, Sklar AH, et al., Correlates of brain edema in uncontrolled IDDM. Diabetes. 1992;41(5):627-632.

Further reading:

Module Content

Expand All

Leave a Reply

BACK TO POST